Trinity League India Ltd

TRINITYLEA

Watchlist

AI Mode

‌

Market Cap

₹ 10 Cr

P/E

—

‌

‌
‌

‌

‌
‌

Investment Checklist

How to read checklist?

Performance

STEADY PERFORMER

Valuation

OVERVALUED

Growth

STABLE

Profitability

MODERATE MARGIN

Technicals

Bullish

Risk

MODERATE RISK

Investment Checklist

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

Price

PE Ratio

Price

‌

Overview

Detailed Summary

Trinity League India Ltd. specializes in the manufacture of homoeopathic medicines, healthcare products, and herbal hair care products, operating two manufacturing units in Delhi.

The company initially started as Dr. Wellman's Homoeopathic Laboratory Ltd. in 1988, becoming a public limited entity in 1995, signaling growth and expansion.

In the mid-1990s, Trinity League India undertook significant expansion and modernization efforts to scale up its production capabilities across several product categories.

Notably, the company was a pioneer in launching homeopathic medicines in blister packs in 1996-97, marking a significant innovation in product delivery methods in India.

The company's name change to Trinity League India Ltd. in 2012 represents its evolving corporate identity and strategic rebranding.

Sector

Finance

Industry

Finance - Investment / Others

Market Cap

10 Cr

Volatility

Low Risk

P/E Ratio

—

Industry P/E

30.0

PEG Ratio

—

P/B Ratio

3.8

52W High

15.74

52W Low

9.01

Sales CAGR

60.00%

-47.03%

4.04%

10Y

-6.78%

Profit CAGR

88.52%

—

10Y

—

ROE

TTM

-1.39%

-27.51%

-17.41%

10Y

-8.68%

ROCE

TTM

-0.95%

-26.14%

-15.30%

10Y

-6.66%

Technicals

‌

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
VIKALPS	35.74	11 Cr	—	4.65	0.00	-28.23	-36.96	-26.07
VBIND	8.10	11 Cr	81.00	0.11	0.00	0.13	0.30	-0.14
SVAMSOF	6.37	10 Cr	—	0.54	0.00	-0.39	0.31	-0.33
TRINITYLEA	12.79	10 Cr	—	3.80	0.00	-1.39	-0.95	-1.11
REGAL	32.28	10 Cr	20.83	4.67	0.00	22.44	24.24	18.18
SHGANEL	17.64	10 Cr	—	2.52	0.00	-82.70	-85.28	-63.02
LIBORD	18.18	9 Cr	—	2.38	0.00	-24.99	-27.84	-24.94

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Revenue	0.00	0.00	0.06	0.00	0.00	0.01	0.00	0.26	0.00	0.00
Expenses	0.07	0.07	0.07	0.07	0.07	0.10	0.08	0.10	0.11	0.14
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financing Profit	-0.07	-0.07	-0.01	-0.07	-0.07	-0.09	-0.08	0.16	-0.11	-0.14
Financing Margin %	—	—	-16.67	—	—	-900.00	—	61.54	—	—
Other Income	-0.59	-0.65	0.17	-1.33	-0.32	0.06	0.03	0.07	0.04	0.04
Depreciation	0.02	0.02	0.02	0.02	0.01	0.01	0.01	0.01	0.01	0.01
Profit Before Tax	-0.68	-0.75	0.14	-1.42	-0.40	-0.05	-0.06	0.22	-0.08	-0.10
Tax %	1.47	1.33	7.14	-0.70	0.00	0.00	0.00	4.55	0.00	0.00
Net Profit	-0.67	-0.74	0.14	-1.43	-0.40	-0.05	-0.06	0.21	-0.08	-0.10
EPS in Rs	-0.85	-0.93	0.17	-1.80	-0.51	-0.06	-0.08	0.26	-0.10	-0.13
Gross NPA %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net NPA %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Revenue	0.22	0.76	1.79	3.36	0.06	0.27	0.27
Expenses	0.50	0.65	1.52	3.09	0.29	0.34	0.39
Interest	0.04	0.06	0.10	0.12	0.00	0.00	0.00
Financing Profit	-0.32	0.05	0.17	0.15	-0.23	-0.07	-0.12
Financing Margin %	-146.45	6.64	9.35	4.49	-379.94	-27.82	-44.44
Other Income	0.21	-0.44	0.14	0.10	-2.40	-0.17	0.20
Depreciation	0.09	0.07	0.10	0.10	0.07	0.05	0.04
Profit Before Tax	-0.19	-0.46	0.21	0.15	-2.71	-0.30	0.03
Tax %	2.21	-7.69	-0.24	27.93	0.17	-3.98	33.33
Net Profit	-0.19	-0.49	0.21	0.11	-2.70	-0.31	0.02
EPS in Rs	—	-0.62	0.26	0.10	-3.41	-0.39	-0.05
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	5.07	5.07	5.07	7.92	7.92	7.92
Reserves	-2.28	-2.80	-2.60	-2.06	-4.77	-5.07
Borrowings	0.77	0.80	1.42	0.01	0.00	0.00
Other Liabilities	0.08	0.04	0.23	0.13	0.09	0.04
Total Liabilities	3.64	3.11	4.11	6.00	3.24	2.88
Fixed Assets	0.33	0.50	0.40	0.30	0.22	0.17
CWIP	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.84	1.68	3.04	3.03	0.38	0.00
Other Assets	2.46	0.93	0.68	2.67	2.64	2.71
Total Assets	3.64	3.11	4.11	6.00	3.24	2.88

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	2,358	-0.24	1.42	0.35	-2.08	-0.23	-0.21
Cash from Investing Activity	-1,306	-0.25	-1.56	-0.97	0.21	0.25	0.21
Cash from Financing Activity	-1,019	-0.07	-0.04	0.62	1.87	-0.01	0.00
Net Cash Flow	33	-0.56	-0.18	-0.00	0.01	0.00	0.01

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Promoters	54.80%	59.70%	59.70%	59.70%	59.70%	59.70%	59.70%	61.01%	61.01%	61.01%	61.01%	61.01%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	45.20%	40.30%	40.30%	40.30%	40.30%	40.30%	40.30%	38.99%	38.99%	38.99%	38.99%	38.99%
Total Shareholders	2,043	2,035	2,029	2,053	2,066	2,099	2,163	2,341	2,399	2,449	2,491	2,483

Market Transactions

Date	Party	Category	Type	Avg Price (₹)	Total Value (₹)	Quantity	Percent Traded
Nov 13, 2024	Manju jain	Bulk	Sell	16.31	0.07 Cr	43,053	0.54
Nov 13, 2024	Kasturchand jethmal kochar	Bulk	Buy	16.89	0.08 Cr	50,000	0.63
Nov 05, 2024	Rajesh jain huf	Bulk	Sell	15.01	0.09 Cr	59,680	0.75
Sep 11, 2024	Harish verma	Bulk	Sell	14.75	0.08 Cr	54,009	0.68
Sep 05, 2024	Santosh kumawat	Bulk	Sell	13.90	0.08 Cr	55,000	0.69
Sep 02, 2024	Jain akhilesh	Bulk	Buy	12.86	0.06 Cr	43,750	0.55
Sep 02, 2024	Amisha jain	Bulk	Sell	12.93	0.09 Cr	73,325	0.92
Aug 30, 2024	Jain akhilesh	Bulk	Buy	13.55	0.09 Cr	65,362	0.82
Aug 30, 2024	Ashok kumar jain	Bulk	Sell	13.61	0.12 Cr	84,658	1.06
Aug 14, 2024	Multiplier share & stock advi...	Bulk	Buy	18.75	0.03 Cr	14,491	0.18

Projection

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

AI Mode

Oscillators

BearishNeutralBullish

Neutral

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Moving Averages

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Revenue	0.00	0.00	0.06	0.00	0.00	0.01	0.00	0.26	0.00	0.00
Expenses	0.07	0.07	0.07	0.07	0.07	0.10	0.08	0.10	0.11	0.14
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financing Profit	-0.07	-0.07	-0.01	-0.07	-0.07	-0.09	-0.08	0.16	-0.11	-0.14
Financing Margin %	—	—	-16.67	—	—	-900.00	—	61.54	—	—
Other Income	-0.59	-0.65	0.17	-1.33	-0.32	0.06	0.03	0.07	0.04	0.04
Depreciation	0.02	0.02	0.02	0.02	0.01	0.01	0.01	0.01	0.01	0.01
Profit Before Tax	-0.68	-0.75	0.14	-1.42	-0.40	-0.05	-0.06	0.22	-0.08	-0.10
Tax %	1.47	1.33	7.14	-0.70	0.00	0.00	0.00	4.55	0.00	0.00
Net Profit	-0.67	-0.74	0.14	-1.43	-0.40	-0.05	-0.06	0.21	-0.08	-0.10
EPS in Rs	-0.85	-0.93	0.17	-1.80	-0.51	-0.06	-0.08	0.26	-0.10	-0.13
Gross NPA %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net NPA %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Revenue	0.22	0.76	1.79	3.36	0.06	0.27	0.27
Expenses	0.50	0.65	1.52	3.09	0.29	0.34	0.39
Interest	0.04	0.06	0.10	0.12	0.00	0.00	0.00
Financing Profit	-0.32	0.05	0.17	0.15	-0.23	-0.07	-0.12
Financing Margin %	-146.45	6.64	9.35	4.49	-379.94	-27.82	-44.44
Other Income	0.21	-0.44	0.14	0.10	-2.40	-0.17	0.20
Depreciation	0.09	0.07	0.10	0.10	0.07	0.05	0.04
Profit Before Tax	-0.19	-0.46	0.21	0.15	-2.71	-0.30	0.03
Tax %	2.21	-7.69	-0.24	27.93	0.17	-3.98	33.33
Net Profit	-0.19	-0.49	0.21	0.11	-2.70	-0.31	0.02
EPS in Rs	—	-0.62	0.26	0.10	-3.41	-0.39	-0.05
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	5.07	5.07	5.07	7.92	7.92	7.92
Reserves	-2.28	-2.80	-2.60	-2.06	-4.77	-5.07
Borrowings	0.77	0.80	1.42	0.01	0.00	0.00
Other Liabilities	0.08	0.04	0.23	0.13	0.09	0.04
Total Liabilities	3.64	3.11	4.11	6.00	3.24	2.88
Fixed Assets	0.33	0.50	0.40	0.30	0.22	0.17
CWIP	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.84	1.68	3.04	3.03	0.38	0.00
Other Assets	2.46	0.93	0.68	2.67	2.64	2.71
Total Assets	3.64	3.11	4.11	6.00	3.24	2.88

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	2,358	-0.24	1.42	0.35	-2.08	-0.23	-0.21
Cash from Investing Activity	-1,306	-0.25	-1.56	-0.97	0.21	0.25	0.21
Cash from Financing Activity	-1,019	-0.07	-0.04	0.62	1.87	-0.01	0.00
Net Cash Flow	33	-0.56	-0.18	-0.00	0.01	0.00	0.01

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
VIKALPS	35.74	11 Cr	—	4.65	0.00	-28.23	-36.96	-26.07
VBIND	8.10	11 Cr	81.00	0.11	0.00	0.13	0.30	-0.14
SVAMSOF	6.37	10 Cr	—	0.54	0.00	-0.39	0.31	-0.33
TRINITYLEA	12.79	10 Cr	—	3.80	0.00	-1.39	-0.95	-1.11
REGAL	32.28	10 Cr	20.83	4.67	0.00	22.44	24.24	18.18
SHGANEL	17.64	10 Cr	—	2.52	0.00	-82.70	-85.28	-63.02
LIBORD	18.18	9 Cr	—	2.38	0.00	-24.99	-27.84	-24.94

Overview

Detailed Summary

Trinity League India Ltd. specializes in the manufacture of homoeopathic medicines, healthcare products, and herbal hair care products, operating two manufacturing units in Delhi.

The company initially started as Dr. Wellman's Homoeopathic Laboratory Ltd. in 1988, becoming a public limited entity in 1995, signaling growth and expansion.

In the mid-1990s, Trinity League India undertook significant expansion and modernization efforts to scale up its production capabilities across several product categories.

Notably, the company was a pioneer in launching homeopathic medicines in blister packs in 1996-97, marking a significant innovation in product delivery methods in India.

The company's name change to Trinity League India Ltd. in 2012 represents its evolving corporate identity and strategic rebranding.

Sector

Finance

Industry

Finance - Investment / Others

Market Cap

10 Cr

Volatility

Low Risk

P/E Ratio

—

Industry P/E

30.0

PEG Ratio

—

P/B Ratio

3.8

52W High

15.74

52W Low

9.01

Sales CAGR

60.00%

-47.03%

4.04%

10Y

-6.78%

Profit CAGR

88.52%

—

10Y

—

ROE

TTM

-1.39%

-27.51%

-17.41%

10Y

-8.68%

ROCE

TTM

-0.95%

-26.14%

-15.30%

10Y

-6.66%